InMode Ltd
(STU:154)
€
13.22
+0.13 (+0.99%)
Market Cap: 763.67 Mil
Enterprise Value: 332.68 Mil
PE Ratio: 12.45
PB Ratio: 1.45
GF Score: 91/100 Inmode Ltd at Barclays Global Healthcare Conference Transcript
Mar 15, 2023 / 01:30PM GMT
Release Date Price:
€29.2
(-0.68%)
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst
Good morning, everybody. We'll begin our next session. My name is Matt Miksic. I cover medical devices here in the U.S. at Barclays. I'm very pleased to have with us today, InMode. We've got Yair Malca, Chief Financial Officer; and we've also got Spero. I'm not going to try to pronounce your last name.
Spero Theodorou
InMode Ltd. - Chief Medical Officer
Okay. Theodorou, like Theodore Roosevelt.
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst
Okay. Theodorou, Chief Medical Officer.
Questions & Answers
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst
So I wanted to maybe start with just one of the things about InMode that I think catches a lot of medical device folks a little bit offguard, and you probably answer this question all the time here, is the growth model. I think the first conversation we had and I'm relatively
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot